[1] |
Kaida K,Kusunoki S,KanzakiM,et al.Anti-GQ1b antibody as a factor predictive ofmechanical ventilation in Guillain-Barre syndrome[J].Neurol,2004,62(5):821-824.
|
[2] |
李海峰.Guillain-Barre综合征和Miller Fisher综合征的新诊断分类和标准[J].中国神经免疫学和神经病学杂志,2014,21(6):441-443.
|
[3] |
Jin JY,Ryu OH,Lee JK,et al.Recurrent anti-GQ1b antibody syndrome[J].JKorean Neurol Assoc,2014,32(1):19-21.
|
[7] |
Chan JW.Optic neuritis in anti-GQ1b positive recurrentMiller Fishersyndrome[J].Br JOphthalmol,2003,87(9):1185-1186.
|
[11] |
张在强.抗糖脂抗体与周围神经细病[J].继续医学教育,2006,6:123-125.
|
[12] |
杨永,立伟,陈念东,等.Miller-Fisher综合征的临床特点:22例病例分析及文献回顾[J].中国医学创新,2014,17(11):151-152.
|
[14] |
李海峰,袁锦楣.Miller-Fisher综合征发病机制和临床[J].中国临床神经病学杂志,2001,9(4):410-413.
|
[4] |
Wakedey BR,Uncini A,Yuki N,et al.Guillain-Barréand Miller Fisher syndromes-new diagnostic classification[J]. Nat Rev Neurol,2014,10(9):537-544.
|
[5] |
Tuzun E,Kurtuneu M,Lang B,et al.Biekerstaff′s encephalitis and Miller Fisher syndrome associated with voltage gated potassium channel and novel antineuronal antibodies[J].Eur JNeurol,2010,17(10):1304-1307.
|
[6] |
Kannan MA,Ch PK,Jabeen SA,et al.Clinical,electr ophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barre syndrome[J].Neurol India,2011,59(5):727-732.
|
[8] |
Yamaji K,Atsumi M,Saigoh K,et al.Internal ophthalmoplegia in actute oropharyngeal palsy with anti-GQ1b and anti-GT1a IgGantilxxlies[J].NO To Shinkei,2005,57(6):523-526.
|
[9] |
Odaka M,Koga M,Yuki N,et al.Longitudinal changes of antK5iganglioside antibodies before and after Guillain Barre syndrome onset subsequent to Campylobaeter jejunienteritis [J].JNeurol Sci,2003,210(12):99-103.
|
[10] |
Kaida K,Kusunoki S.Antibodies to gangliosides and ganglioside complexes in Guillain-Barrésyndrome and Fisher syndrome:mini-review[J].JNeuroimmunol,2010,223(1-2):5-12.
|
[13] |
Jacobs BC,OHanlon GM,Bullens RW,et al.Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding[J].Brain,2003,126(Pt 10):2220-2234.
|
[15] |
Willison HJ,O′HanionGM.The immunopathogenesisofmiller Fisher syndrone[J].JNeuroimmunol,1999,100(1-2):312.
|
[16] |
Chang T,de Alwis JS,Samarasekara N,etal.Cerebral infaretion 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome:a case report[J].JMed Case Rep,2014,24 (8):1752-1757.
|